H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Microbiology D-index 57 Citations 22,085 135 World Ranking 1338 National Ranking 566
Medicine D-index 79 Citations 41,219 258 World Ranking 10327 National Ranking 5538

Research.com Recognitions

Awards & Achievements

1999 - Member of the National Academy of Medicine (NAM)

1995 - Fellow of the American Association for the Advancement of Science (AAAS)

1995 - Fellow of the American Association for the Advancement of Science (AAAS)

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Cancer

His scientific interests lie mostly in Acquired immunodeficiency syndrome, Immunology, Intensive care medicine, Internal medicine and Viral load. The Acquired immunodeficiency syndrome study combines topics in areas such as Viral disease, Disease, MEDLINE and Virology. The various areas that Paul A. Volberding examines in his Immunology study include Antiretroviral treatment, Antiretroviral therapy and Sarcoma.

His research integrates issues of Regimen, Pharmacotherapy, Raltegravir and Emtricitabine in his study of Intensive care medicine. His study focuses on the intersection of Internal medicine and fields such as Zidovudine with connections in the field of Placebo. His Viral load study combines topics in areas such as Abacavir/Lamivudine and Anti-Retroviral Agents.

His most cited work include:

  • Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents (4138 citations)
  • The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind placebo-controlled trial. (2708 citations)
  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel (2345 citations)

What are the main themes of his work throughout his whole career to date?

Paul A. Volberding mainly investigates Acquired immunodeficiency syndrome, Immunology, Internal medicine, Intensive care medicine and Virology. His Acquired immunodeficiency syndrome study which covers Family medicine that intersects with Gerontology. His Immunology study integrates concerns from other disciplines, such as Pharmacotherapy, Epidemiology and Sarcoma.

Asymptomatic, Placebo and Randomized controlled trial is closely connected to Zidovudine in his research, which is encompassed under the umbrella topic of Internal medicine. In his research, Protease inhibitor is intimately related to Regimen, which falls under the overarching field of Intensive care medicine. His Virology research is multidisciplinary, incorporating perspectives in Antibody and Antigen.

He most often published in these fields:

  • Acquired immunodeficiency syndrome (46.62%)
  • Immunology (34.80%)
  • Internal medicine (33.45%)

What were the highlights of his more recent work (between 2009-2021)?

  • Acquired immunodeficiency syndrome (46.62%)
  • Family medicine (10.14%)
  • Internal medicine (33.45%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Acquired immunodeficiency syndrome, Family medicine, Internal medicine, Intensive care medicine and Clinical trial. His Acquired immunodeficiency syndrome research is multidisciplinary, incorporating elements of Health care, Health policy, Gerontology, Regimen and Immunology. His Immunology study frequently links to other fields, such as Pharmacotherapy.

His study brings together the fields of Oncology and Internal medicine. Paul A. Volberding has included themes like MEDLINE, Integrase strand transfer inhibitor, Adverse effect, Disease and Pre-exposure prophylaxis in his Intensive care medicine study. His Clinical trial research includes themes of Cancer, Treatment strategy, Randomized controlled trial and Etoposide.

Between 2009 and 2021, his most popular works were:

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel (414 citations)
  • HIV and aging: State of knowledge and areas of critical need for research. a report to the NIH office of AIDS research by the HIV and aging working group (373 citations)
  • Antiretroviral therapy and management of HIV infection (319 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Cancer

Paul A. Volberding mostly deals with Acquired immunodeficiency syndrome, Intensive care medicine, Family medicine, Disease and Internal medicine. His work carried out in the field of Acquired immunodeficiency syndrome brings together such families of science as Clinical trial, Health care and Age of onset. His Intensive care medicine research incorporates themes from Integrase inhibitor, Regimen, Pharmacotherapy and Pre-exposure prophylaxis.

His studies link Immunology with Pharmacotherapy. His studies deal with areas such as Therapeutic approach and Incidence as well as Immunology. His study in Internal medicine is interdisciplinary in nature, drawing from both DNA and Oncology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind placebo-controlled trial.

Margaret A Fischl;D. D. Richman;M. H. Grieco;M. S. Gottlieb.
The New England Journal of Medicine (1987)

4437 Citations

Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents

A. S. Fauci;J. G. Bartlett;E. P. Goosby;M. D. Smith.
Annals of Internal Medicine (1998)

4165 Citations

Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy.
JAMA (2008)

2345 Citations

Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection: A Controlled Trial in Persons with Fewer Than 500 CD4-Positive Cells per Cubic Millimeter

Paul A. Volberding;Stephen W. Lagakos;Matthew A. Koch;David K. Booth.
The New England Journal of Medicine (1990)

1710 Citations

Non-Hodgkin's Lymphoma in 90 Homosexual Men: Relation to Generalized Lymphadenopathy and the Acquired Immunodeficiency Syndrome

John L. Ziegler;Jay A. Beckstead;Paul A. Volberding;Donald I. Abrams.
The New England Journal of Medicine (1984)

1393 Citations

Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society–USA Panel

Charles C. J. Carpenter;David A. Cooper;Margaret A. Fischl;Jose M. Gatell.
JAMA (2000)

1369 Citations

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.

Raymond T. Chung;Janet Andersen;Paul Volberding;Gregory K. Robbins.
The New England Journal of Medicine (2004)

1137 Citations

Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel

Patrick G. Yeni;Scott M. Hammer;Charles C. J. Carpenter;David A. Cooper.
JAMA (2002)

965 Citations

Antiretroviral Therapy for HIV Infection in 1997: Updated Recommendations of the International AIDS Society—USA Panel

Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch.
JAMA (1997)

962 Citations

Antiretroviral Therapy for HIV Infection in 1998: Updated Recommendations of the International AIDS Society–USA Panel

Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch.
JAMA (1998)

956 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Paul A. Volberding

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 291

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 206

Kenneth H. Mayer

Kenneth H. Mayer

Fenway Health

Publications: 143

Douglas D. Richman

Douglas D. Richman

University of California, San Diego

Publications: 137

David A. Cooper

David A. Cooper

Pfizer (United States)

Publications: 130

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 129

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 122

Richard D. Moore

Richard D. Moore

Johns Hopkins University

Publications: 117

Vincent Soriano

Vincent Soriano

Hospital Universitario La Paz

Publications: 110

Adriano Lazzarin

Adriano Lazzarin

Vita-Salute San Raffaele University

Publications: 100

Joseph D. Tucker

Joseph D. Tucker

University of London

Publications: 96

Joseph J. Eron

Joseph J. Eron

University of North Carolina at Chapel Hill

Publications: 96

Caroline Sabin

Caroline Sabin

University College London

Publications: 91

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 88

Dominique Costagliola

Dominique Costagliola

Université Paris Cité

Publications: 85

Michael S. Saag

Michael S. Saag

University of Alabama at Birmingham

Publications: 83

Something went wrong. Please try again later.